Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.
Sahin KB, Shah ET, Ferguson GP, Molloy C, Kalita-de Croft P, Hayes SA, Hudson A, Colvin E, Kamitakahara H, Harvie R, Hasovits C, Khan T, Duijf PHG, Howell VM, He Y, Bolderson E, Hooper JD, Lakhani SR, Richard DJ, O'Byrne KJ, Adams MN.
Sahin KB, et al.
Cancers (Basel). 2021 Sep 16;13(18):4651. doi: 10.3390/cancers13184651.
Cancers (Basel). 2021.
PMID: 34572879
Free PMC article.